WebCo-Founder, President and CEO at Synkine Therapeutics Greater Boston. Synkine Therapeutics, +15 more Harvard Medical School, +4 more Nina Fisherman Chemistry and … WebSep 29, 2024 · Synerkine Pharma Overview. Founded Year 2024. Location Naarden, Netherlands. Company Stage Series A. Total Funding $7.67M. Last Funding Round …
ANGELA BELLUOMINI , Quality & quality director, genentech
WebTo address the key limitations of current cytokine therapeutics and cell therapies, we are developing potentially paradigm-changing medicines using three distinct protein … Pablo Cagnoni, M.D., has led the development, approval, and/or … We believe our platforms enable us to engineer next-generation cytokine … Our most advanced product candidate, STK-012, is a modified IL-2 cytokine. IL-2 is a … Synthekine Launches with $82 Million Series A Financing to Advance Pipeline of … Join us as we adventure beyond conventional scientific thinking. At … 1505 O’Brien Drive Menlo Park, California 94025. PHONE. (650) 271-9888 WebSYNKINE THERAPEUTICS, INC. is a Massachusetts Domestic Profit Corporation filed on June 8, 2024. The company's File Number is listed as 001331541. The Registered Agent … trinet means in smart
Synerkine Pharma LinkedIn
WebTherapeutics. Headquarters Regions San Francisco Bay Area, West Coast, Western US. Founded Date 2024. Founders David Ott, Jason Barbour. Operating Status Active. Last … WebSynkine Therapeutics, Inc. Jul 2024 - Present 4 years 7 months. Greater Boston Area Managing Partner FAS123 Solutions, LLC 2005 - Present 18 years ... WebCo-Founder, President and Chief Executive Officer @ Synkine Therapeutics; Member, Board of Directors @ Allomek Therapeutics; see more Advisor @ Curelator Inc. Member, Board … tesla electric charger install